Cargando…

Editorial: Complement and Immunotherapeutics

Detalles Bibliográficos
Autores principales:	Okrój, Marcin, Volokhina, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943609/ https://www.ncbi.nlm.nih.gov/pubmed/33717205 http://dx.doi.org/10.3389/fimmu.2021.663459

Ejemplares similares

Editorial: Expert opinions and perspectives in complement: 2022
por: Okrój, Marcin, et al.
Publicado: (2023)

Complement Activation as a Helping Hand for Inflammophilic Pathogens and Cancer
por: Okrój, Marcin, et al.
Publicado: (2019)

Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases
por: Michels, Marloes A. H. M., et al.
Publicado: (2018)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
por: Estrada García, Iris, et al.
Publicado: (2021)

Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
por: Felberg, Anna, et al.
Publicado: (2019)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
por: Felberg, Anna, et al.
Publicado: (2020)

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
por: Gustafsson, Kenth, et al.
Publicado: (2020)

Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies
por: Zheng, Ping, et al.
Publicado: (2023)

Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
por: Shaughnessy, Jutamas, et al.
Publicado: (2020)

Editorial: The Role of Complement in Tumors
por: Rolfe, Barbara E., et al.
Publicado: (2020)

Editorial: The complement system in autoimmunity
por: Wu, Eveline Y., et al.
Publicado: (2022)

Editorial: The Role of Complement in Microbial Infections
por: Stoiber, Heribert, et al.
Publicado: (2021)

Editorial: The Role of Complement in Health and Disease
por: Cedzyński, Maciej, et al.
Publicado: (2019)

Editorial: Complement and COVID-19 Disease
por: Prohászka, Zoltán, et al.
Publicado: (2022)

Substitutions at position 263 within the von Willebrand factor type A domain determine the functionality of complement C2 protein
por: Kuźniewska, Alicja, et al.
Publicado: (2022)

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d
por: Kowalska, Daria, et al.
Publicado: (2022)

Editorial: Complement in the Development and Regeneration of the Nervous System
por: Brennan, Faith H., et al.
Publicado: (2021)

Editorial: Function and Dysfunction of Complement Factor H
por: Józsi, Mihály, et al.
Publicado: (2022)

Editorial: Updates on the complement system in kidney diseases
por: Bulla, Roberta, et al.
Publicado: (2023)

Immunotherapeutic Potential of Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2014)

Editorial: Antimicrobial Peptides and Complement – Maximising the Inflammatory Response
por: Stover, Cordula M.
Publicado: (2015)

Editorial: Interactions of Pentraxins and Complement in Infection, Inflammation, and Cancer
por: Ma, Ying Jie, et al.
Publicado: (2022)

Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge
por: Senent, Yaiza, et al.
Publicado: (2021)

Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome
por: de Jong, Sarah, et al.
Publicado: (2022)

Editorial: New insights into the role of complement system in liver diseases
por: Guo, Zhenya, et al.
Publicado: (2023)

TREX1 as a Novel Immunotherapeutic Target
por: Hemphill, Wayne O., et al.
Publicado: (2021)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Immunotherapeutic progress and application of bispecific antibody in cancer
por: Kang, Jingyue, et al.
Publicado: (2022)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein
por: Urban, Aleksandra, et al.
Publicado: (2021)

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Editorial: State-of-the-Art Research on C1q and the Classical Complement Pathway
por: Kishore, Uday, et al.
Publicado: (2016)

Editorial: Therapeutic Modulation of the Complement System: Clinical Indications and Emerging Drug Leads
por: Mastellos, Dimitrios C., et al.
Publicado: (2020)

Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera
por: Okroj, Marcin, et al.
Publicado: (2012)

Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
por: Dong, Zhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8bqbe6t3600hno5rgaheh642a